Therapeutic Delivery – News and Features
News
Experimental Drug Shows Promise for Inflammatory Skin Conditions
A new approach to treat rosacea and other inflammatory skin conditions by inhibiting mast cells could be on the horizon.
News
Mini Robots Target Tumor Cells for Precision Drug Delivery
Using the microrobots, the team successfully delivered therapeutics that decreased the size of bladder tumors in mice.
News
Shape-Changing Polymer Could Advance Soft Robots, Artificial Muscles
A new shape-changing polymer that can move in several directions could transform how soft materials and soft robots are constructed.
News
Carbon Capture Abilities of MOF Material Doubled Using Ammonia Gas
Oregon State researchers discovered that exposing a copper-based MOF to ammonia gas doubles its CO2 adsorption ability. This method enhances carbon capture efficiency without increasing regeneration energy.
News
Contact Lenses That Deliver Drugs for Eye Conditions
University of Waterloo researchers developed 3D-printed hydrogel-loaded contact lenses that deliver medication continuously while worn. The silicone-based hydrogel is durable, flexible and can encapsulate drugs like amoxicillin.
News
Custom-Designed Nanostructures Developed Using DNA Origami
Researchers have developed programmable DNA nanostructures using DNA origami. These customizable nanobots have vast applications, from targeted drug delivery and adaptive materials to energy-efficient optical systems.
News
Nanorobotic “Hand” Can Grab Viruses for Diagnostics and Block Cell Entry
A tiny, four-fingered “hand” folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them.
News
Gene Therapy for Placental Insufficiency Nears Human Trials
Researchers developed a gene therapy to enhance placental function by delivering IGF-1 DNA using nanoparticles. Tested in rhesus macaques, the therapy improved placental health without adverse effects.
News
Nasal Spray Drug Shows Promise in Animal Models of Alzheimer’s
A nasal spray drug can counteract the cognitive decline and brain damage typical of Alzheimer's disease in animal models.
News
New Platform Facilitates Drug Delivery Across the Blood-Brain Barrier
A Mount Sinai team has developed a blood-brain barrier-crossing conjugate (BCC) platform, enabling therapeutic molecules to target the brain. The system effectively silenced disease-related genes like Sod1 in ALS and Mapt in Alzheimer’s.
Advertisement